fbpx

Australians encouraged to know their medicines this World Patient Safety Day

17 September 2024

 

On World Patient Safety Day (17 September), pharmacists are encouraging Australians to take three simple steps to limit their risk of medicine misadventure.

 

Each year 250,000 Australians are hospitalised and a further 400,000 present to emergency departments with medicine-related programs, costing the Australian economy approximately $1.4 billion annually. It is estimated that at least half of these hospitalisations are preventable.

 

The Pharmaceutical Society of Australia (PSA) encourages patients to speak to their local pharmacist to learn more about the medications they use, including medicine interactions.

 

PSA National President Associate Professor Fei Sim FPS said pharmacists are experts in helping patients manage their medicines to ensure they are used safely and effectively.

 

“Today we’re urging Australians to know your medicines, the dose you have been prescribed, check medicine interactions, and for those who use multiple medicines, ask your GP about an annual Home Medicines Review which can be provided free of charge to you by a credentialed pharmacist,” she said.

 

“World Patient Safety Day is a great reminder for all Australians to check that they know the doses of their regular medications, and to ask their local pharmacist about possible medicine interactions.

 

“Older people and people living with a disability are more likely to be using more medicines, facing an increased risk of medicine interactions and misadventure. It is priority health populations like these that we particularly urge to see a pharmacist at least annually to review their medicines.

 

“Pharmacists are Australia’s medicines experts, and are here to provide trusted advice to all Australians about the medicines you use.”

 

​More information and research about medicine-related harm in Australia is available at www.psa.org.au/medicine-safety

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Vision for Pharmacists in 2030 launched at PSA24

2 August 2024

 

On the first day of its national conference PSA24, the Pharmaceutical Society of Australia (PSA) has launched its flagship vision for the future of Australian pharmacy practice, Pharmacists in 2030, alongside Federal Health Minister the Hon. Mark Butler MP.

Pharmacists in 2030 is an evolution of PSA’s vision for the future of the pharmacy profession, and the steps that need to be taken to get there. Compared to its predecessor, Pharmacists in 2030 has an increased focus on equity, medicines stewardship and pharmacist wellbeing, while maintaining focus on medicine safety, expanding scope of practice and integration of pharmacists into collaborative care teams.

The vision is a culmination of deep consultation with pharmacists, consumers and other health stakeholders. Informed by consumers across 14 in-depth focus groups, Pharmacists in 2030 describes how the care pharmacists provide will change over the next 6 years’ through the lens of both pharmacists and patients.

Pharmacists in 2030 articulates six key actions to realise this vision:

  • Medicine safety – empowering and supporting pharmacists to reduce risks and minimise harm by advancing medicine safety in practice
  • Medicines stewardship – supporting pharmacists to actively lead and influence effective and judicious medicine use
  • Access to care – providing all consumers greater access to care by increasing and leveraging the accessibility of pharmacists to address unmet health needs
  • Equity – supporting pharmacists to meet the unique needs of vulnerable individuals and priority populations to address the disparity of health status through the provision of appropriate and responsive care
  • Workforce development – equipping and growing the pharmacist workforce to address existing and emerging health challenges
  • Sustainability – driving practice changes that increase the sustainability of the pharmacist workforce, increase social contribution and limit environmental impact

 

These actions empower pharmacists to embrace their full potential to not only meet Australia’s surging health needs over the next six years, but also to build capacity to address health challenges beyond 2030.

PSA National President Associate Professor Fei Sim FPS said that today’s launch built on the growing momentum behind the profession.

“In launching Pharmacists in 2030, we are progressing PSA’s vision for the future of pharmacy practice in Australia,” A/Prof Sim said.

“Our profession has evolved significantly, and continues to evolve, to meet the increasingly complex health needs of Australians, our aging population and overstretched health system. Our communities need us to continue down this path, they need all pharmacists doing more to support safe use of medicines and greater access to care when and where they need it.

Pharmacists in 2030 leverages the appetite for change in our health system, driven by patient needs, and provides a roadmap for the next 6 years on how pharmacists’ full potential can be realised. It helps government, policymakers and funders understand our value and potential.

 

Pharmacists in 2030 challenges the entire health ecosystem to collaboratively drive pharmacy practice to the next level, including policymakers, patients and consumers.

“We know that regulatory change alone is not enough. We need to address the cultural and system factors which hold our profession back and importantly, we cannot continue expecting pharmacists to do more with less.

“Our goal is getting to a point where practice is more efficient, relieving unnecessary administrative burden so that pharmacists can focus on delivering the care that patients need.

“Each one of us, in all areas of practice and specialisations have a role to play in realising this vision by 2030. The daily practice of pharmacists in direct patient-care roles will see the most evolution in their daily roles, enabled by pharmacists practising in non-patient facing roles, including academia, management and leadership.”

Associate Professor Sim also thanked all the pharmacists that participated in consultation on Pharmacists in 2030.

Pharmacists in 2030 is for the future of every pharmacist,” she said.

“Whether responding to the official consultation, speaking to our teams around the country about the future, or contributing to our social media pages – the collective wisdom of our profession and health consumers has built the path forward for all pharmacists.

“I thank Minister Butler for officially launching Pharmacists in 2030 at PSA24, alongside the passionate pharmacists and consumers who shaped it,” Associate Professor Sim concluded.

 

Pharmacists in 2030 is available to pharmacists and the public at www.psa.org.au/pharmacists_in_2030  

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

TRANSCRIPT: PSA National President opening address at PSA24

2 August 2024

 

Thank you, Aunty Joan Bell, for the beautiful and warm Welcome to Country and for sharing her story with us.

 

I too, would like to acknowledge the traditional custodians of the land we meet on today, the Gadigal People of the Eora Nation.

 

In the spirit of reconciliation, PSA acknowledges the Traditional Custodians of Country throughout Australia and their connections to land, sea and community. We pay our respect to their Elders past and present. I personally extend that respect to all Aboriginal and Torres Strait Islander peoples today.

 

Good morning PSA.

 

In preparing today’s opening, I reflected on our journey in the past 2 years.

 

Two years ago, I delivered my first opening plenary at PSA22– I was exhilarated, nervous, but motivated.

 

This time last year, as I delivered my second opening plenary – I, together with the profession that I love dearly, we were solemn. I would say melancholy at times, but we were cautiously hopeful. We were hopeful because of our belief in our profession, in our community we serve, in our resilience, in our impact and our irreplaceable role.

 

Today 12 months later, I stand here, together with you PSA members, my Board, Branch Presidents, Branch Committees and the amazing PSA Team, and the 3 words I’ve chosen are optimistic, assured, and focused.

 

On behalf of our profession, I am grateful to our government. I want to acknowledge and thank our Federal Minister for Health and Aged Care Minister Mark Butler who will be joining us this afternoon, and Assistant Minister Emma McBride, who is present with us today.

 

After 15 months of uncertainty, our profession welcomed the signing of the 8th Community Pharmacy Agreement and Strategic Agreement. I want to acknowledge the work of the Pharmacy Guild of Australia, their National President Prof Trent Twomey and his team, some of them are with us today. The 8CPA has delivered the much-needed certainty our community pharmacy sector needed.

 

Also on behalf of the profession, I am incredible proud of PSA’s achievement and signing of the first, historic, Strategic Agreement on Pharmacist Professional Practice is monumental.

 

For the first time, the Strategic Agreement articulates the Australian Government’s commitment to support the highest standard of professionalism in pharmacy. Through this Agreement, for the very first time our profession as a whole, received formal recognition and support for our professional practice – recognising that we are an essential part of the healthcare team, and importantly the respect that pharmacists deserve as clinicians in this health care system.

 

For the first time, there is shared vision between our profession and the Commonwealth Government to continue to expand the range of primary healthcare services pharmacists provide, regardless of areas of practice.

 

The Strategic Agreement gives recognition to pharmacists’ expertise and contribution to quality use of medicines and medicine safety.

 

It gives confidence to our patients, our funders and our health system. It gives our profession the framework for standards and guidelines moving forward, as we continue to navigate through practice and health landscape changes.

 

Whilst these are all positive news, as I mentioned earlier, we need to remain focused. The work is not done. Whilst there is ongoing funding for HMRs and RMMRs, and that the Aged Care On-site Pharmacist Program has now formally commenced, the work and viability of our credentialed pharmacist workforce will not be forgotten.

 

Regardless of areas of practice, I truly have never felt so positive about the opportunity for pharmacists to reach our full potential. These opportunities are driven by real needs of our patients and our health system.

 

The current Scope of Practice Review is our opportunity – it is what I would describe as a once-in-a-career lifetime opportunity to challenge the very foundation of health system administration – to achieve equity for all health professionals, including pharmacists, in terms of regulations, funding policy and workforce development. Whether it is through our submissions, in formally representing pharmacists on the Expert Advisory Committee, in attending workshops – members can be assured that PSA is making strong representation.

 

What we want to see is:

 

Removing of unnecessary red tapes, empowering pharmacists to achieve our full and top of scope in being stewards of medicines safety, to have responsibility for the outcomes of and accountability for the outcomes of medicine use, and to truly be the first port of call for primary healthcare.

 

Through national harmonisation of states and territories legislation and regulations – patients across the country should be able to access the same level of healthcare access, not just in those areas where their postcodes are in the 4000’s.

 

Direct referral to pathology – if you’re undertaking a medication review, you should be able to order and access pathology tests which are critical to making meaningful recommendations, consistent with treatment guidelines.

 

Whether you are prescribing or undertaking medication management reviews, it makes no sense you can’t send a patient for Medicare funded blood tests relevant to that service. And it certainly does not make sense that you can’t contribute clinical notes to a patient’s health record.

 

There should be consistent funding policies – We should have access to the MBS for consultation, and should be able to prescribe medicines within our scope under the PBS.

 

Same job same pay – We should get paid the same for providing a vaccination as any other immunisers.

 

Our workforce should be supported to be integrated within multidisciplinary care teams in a meaningful way – in terms of roles, recognition and remuneration.

 

We can do more, but we must also be supported and remunerated to do more. We cannot keep adding more work, we cannot keep expecting pharmacists to do more with less.

 

We need technology to be a facilitator, not a barrier.

 

We need the teams around us to take on more technical work so that we can focus on more cognitive work.

 

We need regulation that is up to date, that supports safer, more efficient care, not get in the way of it.

 

We need to spend more time using the full extent of our skills and expertise to provide patient care.

 

These are sensible and very long overdue asks. Once the report is finalised, we urge the government to start implementing the Review’s recommendations immediately.

 

Executed well, this will dramatically simplify our unnecessarily complicated health system and help all health professionals, including pharmacists, increase their capacity to provide care.

 

I want to take this opportunity to thank and acknowledge representatives from the Department of Health and Aged Care for their work, and PSA appreciates your work and we look forward to continuing our collaborative effort to achieve this aim.

 

Australians deserve a health system which functions better than it does now.

 

This afternoon, I hope you will join me in attending Minister Mark Butler’s address.

 

Today Minister Butler will officially launch our vision for the future of pharmacy practice in Australia – Pharmacists in 2030.

 

Pharmacists in 2030 leverages the real appetite for change in our health system, driven by patient needs, and importantly provides a roadmap for the next 6 years on how pharmacists’ full potential can be realised.

 

It helps government, policymakers and funders understand our value and potential.

 

While I won’t spoil its contents, I will say a huge thank you to every one of you, our members, our elected officials, PSA Team, the Australian Pharmacy Leaders Forum member organisations who are also here today, and our consumers, who contributed to this document.

 

Martin Luther King Jr once said: “The ultimate measure of a man is not where he stands in moments of comfort and convenience, but where he stands at times of challenge and controversy.”

 

Pharmacists – We know it hasn’t been easy. We know practice is getting harder and more complex. We know it can be overwhelming. But, we must keep going.

 

As we continue to evolve our profession to meet healthcare needs of Australians, I see the next 5 years as critical in the development and preparation of our workforce.

 

PSA’s work will focus on building a pharmacy workforce which has the capability and capacity to meet the health needs of Australians into the future.

 

No matter what, PSA is pharmacy, and PSA is here throughout our pharmacy career, and we should never feel alone. We are here, we are all here to be your career partner to navigate the future together.

 

It is now time to welcome our Assistant Minister for Mental Health and Suicide Prevention, and Assistant Minister for Rural and Regional Health, Emma McBride, to the stage.

 

 

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA set to launch renewed vision for profession at national conference

31 July 2024

 

The Pharmaceutical Society of Australia (PSA) is thrilled to announce Pharmacists in 2030, its vision for the future of the pharmacy profession, will be launched this weekend at the PSA24 National Conference by Federal Health Minister, the Hon. Mark Butler MP.

 

A culmination of deep consultation with pharmacists, consumers and other health stakeholders, Pharmacists in 2030 describes how the care pharmacists provide will change over the next 6 years through the lens of both pharmacists and patients.

“The release of Pharmacists in 2023 back in 2019 was the first time that a clear vision and framework was developed to unlock the full potential of pharmacists in supporting the health and wellbeing of Australians,” said PSA National President, Associate Professor Fei Sim FPS.

“Hand-in-glove with the profession we have realised much of this vision, but there is still a long way to go.

We are now set to launch the next phase of this vision, Pharmacists in 2030, cementing the core role of pharmacists in medicines expertise and emphasising the ability of pharmacists to improve patient care.

 

“The growing expectations of our patients came through very strongly in our consumer consultation. Consumers have a very high level of trust in pharmacists, and they want us to do more.

 

“As the health needs of Australians continue to grow and become more complex, it is critical that our profession grows too. Pharmacists in 2030 is a roadmap that will guide the path forward to 2030, and beyond,” Associate Professor Sim concluded.

 

The launch of Pharmacists in 2030 will be a highlight of the PSA24 National Conference, where attendees will hear from national and global pharmacy leaders and connect with pharmacy colleagues from around Australia.

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Australians urged to speak to pharmacists as health misinformation grows

24 July 2024

 

The Pharmaceutical Society of Australia (PSA) is today encouraging Australians to leave behind the advice of unverified websites and online influencers and instead visit their local pharmacist for accurate health information as it marks International Self-Care Day.

 

With the increasing availability of unverified and often inappropriate ‘health hacks’ online, PSA recognises the increasingly important role of pharmacists in tackling online misinformation while empowering Australians to be active agents in their own healthcare.

 

As a member Australia Self-Care Alliance PSA promotes the adoption of self-care through pharmacists, maintaining a suite of over 100 Self-Care Fact Cards to provide evidence-based health information to consumers.

 

PSA National President Associate Professor Fei Sim FPS said that misinformation can risk the health and wellbeing of Australians.

 

“Appropriate self-care does not replace the care provided by professionals, but enhances it,” A/Prof Sim said.

 

“Self-care is important as part of keeping yourself and your family healthy, but more and more often we’re seeing consumers getting health information from social media, which is often not based in evidence, and in some cases can be very dangerous.

 

“Pharmacists are registered health professionals who give evidence-based health advice to Australians. Instead of trusting social media influencers and the internet, I strongly encourage patients to speak with their local pharmacist about their health concerns where we can give you accurate health information or refer you on to the right healthcare provider.

 

“Today’s International Self-Care Day is a great reminder not only to look after your health and wellbeing, but also of the importance of following accurate health information,” A/Prof Sim concluded.

 

More information on self-care is available via the World Health Organization.

Pharmacists are encouraged to read the International Pharmaceutical Federation (FIP) resource Empowering self-care: A handbook for pharmacists

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Pharmacists mark NAIDOC Week

8 July 2024

 

This week, the Pharmaceutical Society of Australia (PSA) acknowledges NAIDOC Week from 7 to 14 July 2024, celebrating and recognising the history, culture and achievements of Aboriginal and Torres Strait Islander peoples.

 

The theme of NAIDOC Week 2024 is Keep the Fire Burning! Blak, Loud and Proud.

 

In the spirit of continued learning, PSA continues to encourage all pharmacists practising in Australia to undertake the Deadly Pharmacists Foundation Training Program developed in co-design with the National Aboriginal Community Controlled Health Organisation (NACCHO), growing the cultural knowledge and understanding that underpins quality health care.

 

PSA National President Associate Professor Fei Sim FPS reaffirmed the role of pharmacists in recognising and implementing culturally safe care.

 

“All healthcare professionals have a responsibility to provide health care that is culturally responsive for Aboriginal and Torres Strait Islander Australians,” Associate Professor Sim said.

 

“This NAIDOC Week, PSA once again recognises the important role pharmacists can play in closing the gap and improving health outcomes for First Nations people.”

 

“PSA’s longstanding commitment to culturally safe health care continues to grow, working with Aboriginal and Torres Strait Islander organisations to promote a truly patient-centred model of care that recognises and works with – not against – our patients’ cultures.

 

“We continue to advocate for permanent funding for the integration of pharmacists into Aboriginal and Torres Strait Islander primary health services following a positive MSAC recommendation in 2023. This model of care has been proven to make a significant improvement to the health outcomes of Aboriginal and Torres Strait Islander peoples.

 

The Deadly Pharmacists Foundation Training Program is free and available to all Australian pharmacists. PSA encourages all pharmacists interacting with patients to make a commitment to undertake the training this NAIDOC Week, gaining a better understanding of the health needs of First Nations people.

Additionally, pharmacists who are looking to gain the new MMR credential can upload their certificate of completion of the Deadly Pharmacists Foundation Training program as evidence of APC Performance Outcome 1.1, demonstrating their learning in the area of promoting, maintaining and advocating for cultural safety, respect and responsiveness in relation to Aboriginal and Torres Strait Islander peoples.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA launches credentialing program

2 July 2024

The Pharmaceutical Society of Australia (PSA) has launched its full suite of credentials today, including pathways for both experienced consultant pharmacists and those looking to expand their practice.

The Medication Management Review (MMR) credential and Aged Care Onsite Pharmacist (ACOP) credential are now open for enrolment. Pharmacists with relevant experience can submit evidence of qualifications and/or practical experience as part of a Recognition of Prior Learning pathway for both the MMR and ACOP credentials.

PSA is currently the only education provider to offer a full suite of products, including both credentials and RPL pathways for both. To continue its support for credentialed pharmacists, PSA is offering the MMR Credential through the RPL pathway free of charge for Professional Plus members.

PSA National President Associate Professor Fei Sim FPS said today’s credentialing program launch marks the next milestone in PSA’s package for credentialed pharmacists.

“PSA’s credentialing program is built by pharmacists, for pharmacists,” Associate Professor Fei Sim said. “We are proud to offer a full suite of education and support to our credentialed pharmacist members, from credentialing and all the way through your everyday practice.

“Our support doesn’t stop once you gain your credentials, we are proud to continue supporting you and your practice with regular clinical updates, continued professional development, industry-leading practice support, and the annual Consultant Pharmacist Conference.

“We continue to invest in credentialed and consultant pharmacists, not only through a great membership product and leading training program, but also through our advocacy for the future of comprehensive medication management.

“PSA’s long history of advocating for Medication Management Reviews and Aged Care Onsite Pharmacists does not stop here. We are your voice, we are your peak body.

“PSA is the home of credentialed and consultant pharmacists – issuing the credentials you need to continue in your practice, connecting you with your colleagues, and advocating for the future of the services you provide,” Associate Professor Sim concluded.

Leading consultant pharmacist Adjunct Associate Professor Debbie Rigby FPS welcomed the launch, pointing to PSA’s growing support for credentialed and consultant pharmacists.

“I’m excited to be joining PSA to amplify the voices of consultant pharmacists and the valuable role they play in medication safety and quality use of medicines through multidisciplinary, collaborative care,” Ms Rigby said.

“PSA’s credentials highlight the strong commitment of PSA towards the practice of consultant pharmacy and supporting members to deliver high quality medication management and care.”

PSA’s MMR and ACOP credentials are now open for enrolments. Visit https://www.psa.org.au/career-and-support/credentialed-pharmacists/ for more information. ​

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

PSA partner in PRIDE project, supporting safe and inclusive care for LGBTQIA+ Australians

28 June 2024

 

The Pharmaceutical Society of Australia (PSA) is proudly partnering with the University of Queensland (UQ) to foster inclusive and empowered primary care workforces through the Promoting queer-inclusive professional identities for diversity in primary healthcare (PRIDE co-design) project.

 

Funded through the Medical Research Future Fund (MRFF), the PRIDE project aims to make affirming care more accessible through a national network of empowered LGBTQIA+ practitioners and allies, building capacity of the mainstream primary care sector to address the health needs of the LGBTQIA+ community in a safe and inclusive way.

 

The project will work with a range of peak professional bodies to deliver tailored education to health professionals. As a PRIDE project partner, PSA will offer education and resources to help pharmacists improve the care they provide LGBTQIA+ patients, starting with a session at PSA’s national conference in August.

 

PSA National President Associate Professor Fei Sim FPS said there is still a long way to go to addressing health inequalities for LGBTQIA+ Australians.

 

“Everyone has the right to safe, affirming health care,” Associate Professor Sim said.

 

57% of LGBTQIA+ Australians have reported discrimination due to their sexual orientation, and almost 80% of people who are trans or gender diverse had experienced discrimination due to their gender identity. Stigma and discrimination in the health care context contributes to greater health disparities experienced by LGBTQIA+ communities and can lead to delaying or avoiding healthcare entirely.

 

“As some of the most accessible health care professionals, pharmacists have a duty of care to patients to ensure that healthcare is provided in a way that is inclusive and appropriate for all people.

 

“PSA strongly believes in the potential of PRIDE co-design project to have a transformative impact on the development of inclusive and affirming models of care for LGBTQIA+ people experiencing intersectional disadvantage within our health care system.

 

“We are proud to be working with Dr Ross and her team to provide pharmacists with the resources and training needed to promote truly person-centred care,” A/Prof Sim concluded.

 

PRIDE Project leader and Chief Investigator Dr Megan Ross highlighted the importance of creating a culture of safe and supportive environments for LGBTQIA+ health practitioners, too.

 

“Building the capacity of the primary health workforce to deliver safe and affirming care has to include creating safe and inclusive environments for health providers. Too often we see trans and queer practitioners exit the workforce, we need a culture of inclusion that supports LGBTQIA+ practitioners to remain in the workforce and provide safe and affirming care to the community,” Dr Ross said.

 

“Building multi-disciplinary, connected and trusted network of safe and affirming providers addresses a current gap in primary care.

“A multi-disciplinary affirming provider network will facilitate access to continuous, trustable safe and affirming care across the primary care landscape for LGBTQIA+ consumers, and support LGBTQIA+ practitioners to feel safe and supported in their workplaces.”

 

Delegates attending PSA24 will have the opportunity to connect with the PRIDE Project during the session Does the pharmacy profession get a rainbow tick? presented by Professor Lisa Nissen and Dr Jean Spinks on Sunday 4 August, 2024.

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

Media statement: Vaping reform legislation

26 June 2024

 

The Pharmaceutical Society of Australia (PSA) acknowledges the passing of reforms today that aim to shut down the retail model of vape supply in Australia.

 

The legislation which has now passed the Senate defines the minimum legal requirements for prescribing as a Pharmacist Only Medicine (Schedule 3). In addition, pharmacists will be expected to adhere to PSA’s Guidelines for pharmacists providing smoking cessation support, which will be updated prior to 1 October 2024.

 

While the amendments to the legislation are not PSA’s preferred approach, we also recognise the need for strong action to address the vaping public health crisis, and this starts with ending retail supply of vapes.

 

Quotes attributable to PSA National President Associate Professor Fei Sim:


“PSA has consistently called for strong action to address the public health crisis that vaping has become.

 

“While this is not our preferred model, PSA remains firm in the belief that something needed to be done to prevent another generation of Australians to becoming addicted to nicotine and experiencing the health consequences of vaping.

 

“Once legislation has passed both houses, our focus will be firmly on supporting pharmacists through these changes.

 

“PSA will work with government to support the pharmacists who choose to be involved in the prescribing and dispensing of nicotine-containing therapeutic vapes. PSA will develop best-practice guidelines to describe how pharmacists prescribe products for smoking cessation products, including nicotine-containing therapeutic vapes.

 

“People will not be able to simply buy vapes on request – they must take part in a therapeutic consultation with a pharmacist who will prescribe a therapy based on clinical need.  It will be very different to how Australians are currently buying vapes.

 

“The coming months will be critical in ensuring pharmacists and the community have a clear understanding of how this model will work as a health-based approach to nicotine dependence management.”​

 

Media contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

‘Placement poverty’ affecting future of health sector workforce

6 May 2024

 

The Pharmaceutical Society of Australia (PSA) is pleased to see the Federal Government taking action to relieve cost of living pressure on students undertaking mandatory unpaid placements as part of their studies but warns that students in pharmacy and other allied health professions are being left behind.

 

Students studying pharmacy and paramedicine are among thousands who will fall outside of today’s announcement, with unpaid clinical placements forcing some to give up their education altogether.

 

Under accreditation requirements, pharmacy students are required to undertake clinical placements as part of their course of study.

 

PSA National President Associate Professor Fei Sim said that the government’s recognition of the strain unpaid placements has on students is the first step, but more needs to be done.

 

“Clinical placements are a valuable part of the learning experience, but they cannot come at the expense of our student’s livelihoods,” A/Prof Sim says.

 

“Training the next generation of pharmacists, I see first-hand the pressure unpaid placements put on our students. I’ve seen pharmacy students forced to give up paid work, struggle to make ends meet, and worryingly, drop out of their degrees altogether.

 

“Many placement sites and pharmacist preceptors also do not get any funding to host placement students.

 

“Pharmacy students and the pharmacy profession require support to continue to meet the growing future health needs of Australians. We need more people to pick pharmacy as their career choice, and that support must start now.

 

“All students undertaking compulsory unpaid placements, including pharmacy students, deserve access to government support.

 

“I urge the Federal Government to revisit this policy and offer the same financial support to all health students who are required to undertake clinical placements as part of their studies.”

 

National Australian Pharmacy Students Association (NAPSA) President Bano Serhan echoed calls for pharmacy students to have access to support.

 

“The government has acknowledged that placement poverty deeply affects students, and this is no different for our members,” she says.

 

“Pharmacy students are being left behind in the budget, at a time when they need more support to build a better and more diverse healthcare workforce.”

 

 

PSA contact:   Georgia Clarke   M: 0480 099 798  E: georgia.clarke@psa.org.au

NAPSA contact: Sebastian Harper    M: 0437 926 889  E: treasurer@napsa.org.au

NOTICE: PSA's 1300 caller ID has changed. Click here for more information.
+